Woodside, CA, United States of America

Yi Lin Zhang


Average Co-Inventor Count = 5.3

ph-index = 6

Forward Citations = 140(Granted Patents)


Location History:

  • Woodside, CA (US) (2003)
  • Palo Alto, CA (US) (2011 - 2017)
  • San Francisco, CA (US) (2013 - 2018)
  • Dublin, CA (US) (2018 - 2023)
  • Lexington, MA (US) (2022 - 2023)

Company Filing History:


Years Active: 2003-2023

Loading Chart...
17 patents (USPTO):

Title: The Innovative Contributions of Yi Lin Zhang

Introduction

Yi Lin Zhang is a prominent inventor based in Woodside, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for metabolic disorders and cancer treatment. With a total of 17 patents to his name, Zhang's work has the potential to impact many lives.

Latest Patents

One of Zhang's latest patents involves Growth differentiation factor 15 (GDF-15) polypeptides. These GDF15 polypeptides, along with constructs comprising GDF15 and mutants thereof, are designed for use in treating or ameliorating metabolic disorders. Specifically, they target conditions such as type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. Another significant patent focuses on blocking antibodies against CD47. These anti-CD47 antibodies or fragments can effectively block the interaction between human CD47 and its ligand SIRP alpha, enhancing the phagocytic activity of macrophages to engulf cancer cells. Notably, some of these antibodies do not induce in vitro hemagglutination, making them suitable therapeutic agents with reduced off-target effects.

Career Highlights

Throughout his career, Yi Lin Zhang has worked with notable companies such as UCB Pharma and Amgen Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Zhang has collaborated with esteemed colleagues, including Andrew George Popplewell and YuMei Xiong. These partnerships have fostered an environment of innovation and have led to the development of impactful therapeutic solutions.

Conclusion

Yi Lin Zhang's contributions to biotechnology and his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…